Newsroom
Category
November 6, 2019
A just-released study by UT Health San Antonio and collaborating institutions shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin. This finding, if furthered, holds implications for aging in general and perhaps offers an avenue to prevent Alzheimer’s dementia in some people, said research first […]
October 30, 2019
Media contact: Rosanne Fohn, fohn@uthscsa.edu, (210) 232-5998 Backup media assistance at the event: Olga Coronado, coronadoo@uthscsa.edu, (210) 639-6273 WHAT: About 1,500 high school and college students from throughout South Texas will learn how to perform dissections using some of the newest, high-tech, virtual human anatomy software. They’ll also learn to assist breathing using intubation […]
October 23, 2019
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio is recruiting volunteers for a clinical study of an investigational drug for Alzheimer’s disease. The principal investigator for this study is Sudha Seshadri, M.D., professor of neurology at UT Health San Antonio and director of the Glenn Biggs Institute. The Biggs […]
October 21, 2019
Global research project suggests novel drug targets for brain diseases Researchers have found a link between 48 common genetic variations and the size of the brainstem and other subcortical structures deep within the brain. These structures control a wide array of functions ranging from learning and fear response to heart rate and voluntary movement. Damage […]
October 21, 2019
CONTACT: Rosanne Fohn, fohn@uthscsa.edu, (210) 567-3026 ON-SITE CONTACTS: Julie Collins, (210) 218-8746, and Joel Williams, (210) 837-4015 DIRECTIONS: Enter the Convention Center from Market Street via Lila Cockrell Theatre entrance, then go to River Level NOTE: Conference breaks for lunch off-site from 11:30 a.m. to 1:00 p.m., so no interviews are available at this time […]
October 15, 2019
William L. Henrich, M.D., MACP, president of UT Health San Antonio, joined three fellow presidents on Oct. 15 to discuss the newly announced San Antonio Partnership for Precision Therapeutics. Dr. Henrich participated in a panel with Dr. Taylor Eighmy, president of The University of Texas at San Antonio; Dr. Larry Schlesinger, president of Texas Biomedical […]
